Since angiosarcomas have been reported to represent the signaling abnormalities of pathogenic angiogenesis [4], we speculated that SFRP2 would also be expressed in human angiosarcomas, which we confirmed by immunohistochemistry [5]. This evidence concerns the gene SFRP2 and angiosarcoma.